Seipasa and Valent BioSciences have formed a strategic partnership to expand the availability of next-generation biostimulants in the U.S. market.

Under the agreement, Valent BioSciences will become the exclusive U.S. distributor of Seipasa’s biostimulant portfolio, including the new product Sweetsei. Sweetsei is already used in Latin America, Europe, and Africa to improve crop quality in specialty production.

Valent BioSciences president and CEO Salman Mir said the partnership aligns with the company’s focus on science-driven biological solutions: “Sweetsei is a proven technology that will help farmers optimize their harvest.”

The deal marks a key milestone in Seipasa’s international growth strategy and provides a direct entry into one of the world’s largest agricultural markets. “The United States is a key market in our international expansion,” said Pedro Peleato, CEO of Seipasa.

Valent BioSciences, an Illinois-based subsidiary of Japan’s Sumitomo Chemical, specializes in biological agricultural products and has been expanding its plant enhancement portfolio since 2022.

Seipasa, founded in 1998, develops natural botanical solutions for crop protection and nutrition. The partnership represents Seipasa’s strategic entry into the key U.S. agricultural market while strengthening Valent’s biological product offerings for American growers seeking sustainable farming solutions.